However, in contrast to AC005154.6 and CCNL2, hsa-miR-29c-3p expression was downregulated in PRAD, and the low expression level of hsa-miR-29c-3p indicated worse PFS in PRAD Fig. 9. The gene discussed is CCNL2; the disease is prostate adenocarcinoma.